We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

601881:SSEChina Galaxy Securities Co., Ltd. Class A Analysis

Data as of 2026-03-16 - not real-time

CN¥13.96

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

China Galaxy Securities is trading just above a key support level after a prolonged downtrend, with moving averages stacked in a bearish order and momentum indicators signaling oversold conditions. The stock’s low beta suggests limited sensitivity to broader market swings, while 30‑day volatility remains moderate. Valuation metrics point to a price‑to‑earnings multiple below the sector average and a dividend yield that comfortably exceeds the payout ratio, indicating attractive income potential. However, the balance sheet is strained by high leverage and operating cash flow that remains negative, raising concerns about financial flexibility.
Looking ahead, the company’s robust revenue growth and strong profit margins provide a solid foundation for longer‑term upside, especially if leverage can be managed and cash generation improves. The dividend appears sustainable given the modest payout and ample cash reserves, supporting a case for holding or modest buying. Investors should weigh the short‑term technical rebound potential against the underlying credit risk before deciding on position sizing.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Oversold momentum suggests a possible near‑term bounce
  • Proximity to a strong support level limits downside risk
  • High leverage and negative cash flow increase short‑term uncertainty

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Revenue growth and high profit margins underpin valuation appeal
  • Dividend yield provides attractive income while payout remains modest
  • Valuation is below sector averages, offering a margin of safety

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustained earnings power and strong margins support long‑term earnings growth
  • Low beta and stable dividend enhance total return profile
  • Potential deleveraging could improve financial resilience and unlock further upside

Key Metrics & Analysis

Financial Health

Revenue Growth62.80%
Profit Margin32.29%
P/E Ratio14.0
ROE9.71%
ROA1.75%
Debt/Equity241.47
P/B Ratio1.3
Op. Cash FlowCN¥-31432935424
Industry P/E16.4

Technical Analysis

TrendBearish
RSI28.8
SupportCN¥13.91
ResistanceCN¥15.28
MA 20CN¥14.47
MA 50CN¥15.16
MA 200CN¥16.56
MACDBearish
VolumeStable
Fear & Greed Index72.88

Valuation

GradeFair
TypeBlend
Dividend Yield2.29%

Risk Assessment

Beta0.20
Volatility16.36%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.